Login / Signup

Design of indole- and MCR-based macrocycles as p53-MDM2 antagonists.

Constantinos G NeochoritisMaryam Kazemi MirakiEman M M AbdelraheemEwa SurmiakTryfon Zarganes-TzitzikasBeata ŁabuzekTad A HolakAlexander Dömling
Published in: Beilstein journal of organic chemistry (2019)
Macrocycles were designed to antagonize the protein-protein interaction p53-MDM2 based on the three-finger pharmacophore F19W23L25. The synthesis was accomplished by a rapid, one-pot synthesis of indole-based macrocycles based on Ugi macrocyclization. The reaction of 12 different α,ω-amino acids and different indole-3-carboxaldehyde derivatives afforded a unique library of macrocycles otherwise difficult to access. Screening of the library for p53-MDM2 inhibition by fluorescence polarization and 1H,15N HSQC NMR measurements confirm MDM2 binding.
Keyphrases
  • protein protein
  • small molecule
  • escherichia coli
  • amino acid
  • magnetic resonance
  • molecular docking
  • multidrug resistant
  • single molecule
  • transcription factor
  • mass spectrometry
  • energy transfer